Sobi begins avatrombopag phase 3 trial in immune thrombocytopenia in pediatrics

Swedish Orphan Biovitrum (Sobi) said that the first patient has been dosed with Doptelet (avatrombopag) in a phase 3 trial for the treatment of immune ... Read More